Knight Therapeutics Inc. (TSX:GUD)
6.34
-0.09 (-1.40%)
Sep 12, 2025, 4:00 PM EDT
Knight Therapeutics Market Cap
Knight Therapeutics has a market cap or net worth of CAD 631.81 million as of September 12, 2025. Its market cap has increased by 12.88% in one year.
Market Cap
631.81M
Enterprise Value
620.13M
Revenue
384.56M
Ranking
n/a
PE Ratio
1,649.63
Stock Price
6.34
Market Cap Chart
Since March 3, 2014, Knight Therapeutics's market cap has increased from 84.40M to 631.81M, an increase of 648.61%. That is a compound annual growth rate of 19.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 12, 2025 | 631.81M | 17.97% |
Dec 31, 2024 | 535.57M | -0.95% |
Dec 29, 2023 | 540.73M | -7.35% |
Dec 30, 2022 | 583.64M | -7.29% |
Dec 31, 2021 | 629.56M | -9.50% |
Dec 31, 2020 | 695.69M | -32.33% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Curaleaf Holdings | 2.69B |
Green Thumb Industries | 2.42B |
Trulieve Cannabis | 1.87B |
Sienna Senior Living | 1.66B |
dentalcorp Holdings | 1.63B |
Cronos Group | 1.37B |
WELL Health Technologies | 1.16B |
Extendicare | 1.10B |